LEADERSHIP

Board of Directors

Schalon Newton, DBA

Chair, ANRF Board of Directors

Trefoil Therapeutics
Chief Business Officer

Why Schalon Newton is involved in ANRF:

“With family members who have arthritis I am acutely aware of the challenges of this category of diseases and the limitations that exist with currently available therapies. The early research support that ANRF provides for innovative new approaches to the diagnosis and treatment of these autoimmune conditions is a critical need as government funding is under increasing pressure and corporations increasingly prioritize spending on development projects rather than pure research. ANRF is a uniquely focused organization with the single goal of advancing early stage research.”

Douglas A. Granger, PhD.

Vice Chair, ANRF Board of Directors

Institute for Interdisciplinary Salivary Bioscience Research (IISBR)

Director, Chancellor’s Professor
University of California Irvine

Jonathan Rose

Treasurer, ANRF Board of Directors

Capital Group

Hon. Sally Anne Sheridan

Secretary, ANRF Board of Directors

Mayor of Irvine – 1990-92, City of Irvine City Council – 1984-92 Sotheby’s HOM Real Estate Group

Sally Anne Sheridan is involved in ANRF:

As a former nurse, Mrs. Sheridan has a special passion for the work of the Arthritis National Research Foundation (ANRF). “By funding young researchers with cutting-edge ideas, ANRF is putting money to work in the most effective way to find a cure for these debilitating joint diseases,” she said.

Carl F. Ware, Ph.D.

Chairman, Scientific Advisory Board

SBP Medical Discovery Institute, La Jolla, CA

Director, Infectious and Inflammatory Diseases Center
Professor, Laboratory of Molecular Immunology

Why Carl F. Ware, Ph.D. is involved in ANRF:

Possibilities and challenges are what this researcher, who currently has two important discoveries at various stages of the drug development process, seems to be all about. Dr. Ware hopes that his discoveries will help the 30 to 40 percent of rheumatoid arthritis and Crohn’s sufferers who don’t respond well or at all to the existing TNF based therapies…

Jeffrey Bates

Board Member

Special Counsel Attorney

Jeffrey Bates has been practicing health care law for almost forty years.  His primary focus has been on Medicare and Medi-Cal reimbursement issues, including audits and appeals of audit determinations, compliance, fraud and abuse, and licensing and certification of health care providers.  He practiced in big law firms in Washington, D.C. and Los Angeles, and as an in-house attorney for a long-term care provider in Pasadena, California and Ft. Smith, Arkansas.  Since he retired from full-time practice in 2013, he has been working part time as a solo practitioner out of his home office in Santa Monica, California.

Theresa Hansen

Board Member

RISE Partnerships

Human Resource Director

Kelli Matthews

Board Member

University of Oregon School of Journalism and Communication

Senior Instructor

Verve Northwest Communications

Managing Director

Kelli Matthews has more than 20 years of public relations experience with a focus on research, planning and strategy. She’s been directly responsible for high-level communication, strategic planning, budget management and leadership for a wide variety of organizations.

Kelli has also been an instructor for more than 15 years and her work with undergraduate and graduate students at the University of Oregon’s School of Journalism & Communication has required her to stay on the cutting edge of research and practice in public relations. It’s also given her a chance to work with some talented educators and researchers.

Matthews holds a B.A. in Journalism: Public Relations and an M.A. in Communication and Society from the University of Oregon. Her graduate work focused on international public health promotion.

Richard Salter, Jr.

Board Member

The Salter Group
President

 

Craig Walsh, Ph.D.

Board Member

University of California, Irvine School of Biological Sciences

Professor, Molecular Biology and Biochemistry
Co-Director, Institute for Immunology
Director, Multiple Sclerosis Research Center

Dr. Walsh is an expert in Immunology and his research focuses on the role apoptotic signal transduction plays in the development, activation and homeostasis of the immune system. His lab’s current interests…

Staci Stringer

Board Member

Siskiyou Gifts
Sr. Account Manager

Vespaan Vafadari

Board Member

Moss Adams, LLP
Senior Audit Associate

Director Emeritus

Travis A. Montgomery

The Queen Mary
Retired Vice President and Chief of Staff

Why Travis Montgomery is involved in ANRF:

“It’s exciting to see how far the Foundation has grown from funding research grants only in California to funding quality research programs at some of the most prestigious research centers in America.”

In Memorium

Gale A. Granger, Ph.D. (1937-2018)

University of California, Irvine
Professor of Immunology, Retired

Why Gale A. Granger is involved in ANRF:

Early in his career as a researcher at the University of California, Irvine, Dr. Granger received funding from ANRF to study the immunological processes occurring in the tissue destruction observed in Rheumatoid Arthritis. His subsequent findings changed the world’s treatments in many related fields…

Translate »

Stay up to date with the latest research

Make a Donation

Make a one-time or recurring donation and know that you are making a difference by funding cutting-edge arthritis research.

Skip to content